What is the recommended treatment for trichomoniasis in adults, including pregnant or breastfeeding patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trichomoniasis

First-Line Treatment for Non-Pregnant Adults

The recommended treatment for trichomoniasis is metronidazole 2 grams orally as a single dose, which achieves cure rates of 90-95%. 1, 2

Alternative Regimen

  • Metronidazole 500 mg orally twice daily for 7 days is an acceptable alternative, particularly when adherence to single-dose therapy is uncertain 1, 2, 3
  • Recent evidence suggests the 7-day regimen may be superior to single-dose therapy in women, with failure rates of 11% versus 19% respectively 4
  • However, CDC guidelines continue to endorse the single-dose regimen as first-line due to improved compliance and lower cost 1, 2

Other FDA-Approved Options

  • Tinidazole 2 grams orally as a single dose is equally effective, with cure rates of 92-100% 5, 6
  • Secnidazole 2 grams orally as a single dose offers favorable pharmacokinetics with a longer half-life 7

Treatment During Pregnancy

Metronidazole is absolutely contraindicated during the first trimester of pregnancy due to concerns about fetal organogenesis, as the drug crosses the placental barrier rapidly. 1, 2

Pregnancy-Specific Guidelines

  • If symptomatic trichomoniasis presents during the first trimester, treatment must be delayed until the second trimester begins 1
  • After the first trimester, treat with metronidazole 2 grams orally as a single dose 1, 2, 3
  • The single-dose regimen is specifically recommended for pregnant women rather than the 7-day regimen to minimize total fetal drug exposure 1
  • Treatment after the first trimester is warranted because trichomoniasis is associated with premature rupture of membranes and preterm delivery 1, 2

Breastfeeding Considerations

  • Because metronidazole shows carcinogenic potential in rodent studies, a decision should be made whether to discontinue nursing or discontinue the drug 8
  • Metronidazole is secreted in human milk in concentrations similar to plasma 8

Critical Partner Management

All sexual partners must be treated simultaneously with the same metronidazole regimen, regardless of symptoms, as most infected men are asymptomatic carriers. 1, 2, 3

  • Failure to treat partners is the most common cause of treatment failure and reinfection 1, 2
  • Patients must abstain from sexual intercourse until both partners complete treatment and are asymptomatic 1, 2, 3
  • Most infected men are asymptomatic, making them unknowing vectors of transmission 1

Management of Treatment Failure

Stepwise Approach to Persistent Infection

  • First recurrence: Re-treat with metronidazole 500 mg twice daily for 7 days 1, 2, 3
  • Second failure: Metronidazole 2 grams orally once daily for 3-5 days 1, 2, 3
  • Persistent failure: After excluding reinfection, consult an infectious disease specialist for susceptibility testing 1, 2, 3

Critical Pitfalls to Avoid

Topical metronidazole gel is NOT effective for trichomoniasis and should never be used, as it achieves less than 50% efficacy. 1, 2, 3

Additional Safety Warnings

  • Patients must avoid all alcohol during treatment and for at least 24 hours after the last dose to prevent severe disulfiram-like reactions including nausea, vomiting, flushing, headache, and abdominal cramps 1, 3
  • Topical antimicrobials other than metronidazole have even lower cure rates (<50%) 1
  • Intravaginal metronidazole/miconazole combinations show promise but are not currently standard of care 9

Special Populations

HIV-Infected Patients

  • HIV-infected patients should receive the same treatment regimen as HIV-negative patients 1, 3

Follow-Up

  • Routine follow-up is unnecessary for patients who become asymptomatic after treatment or who are initially asymptomatic 1, 3
  • If symptoms persist after treatment, consider reinfection or resistant infection 3

References

Guideline

Treatment and Prevention of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Single dose treatment of trichomoniasis.

The Journal of international medical research, 1982

Research

Secnidazole: a treatment for trichomoniasis in adolescents and adults.

Expert review of anti-infective therapy, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.